Riskpilot← Back to searchSign inGet full accessCranium Medicare AB
ABActiveOrg 5590535091Solgatan 8Activities of head offices · NACE 7010Est. 20160 employees
Revenue 2024
SEK 325K
+381% vs 2023
EBITDA margin
80.2%
+4671% vs 2023
Equity ratio
65.1%
Financial strength
Net profit 2024
SEK 221K
+21825% vs 2023
| Revenue | SEK 325K | +381% |
| EBITDA | SEK 261K | +4671% |
| Net profit | SEK 221K | +21825% |
| Total assets | SEK 417K | +163% |
| Equity | SEK 272K | +432% |
| Employees | 0 | — |
Legal name
Cranium Medicare AB
Org number
5590535091
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
2 mars 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsultverksamhet inom hälso- och sjukvård, handel och förvaltning av fast egendom samt därmed förenlig verksamhet.
Address
Solgatan 8
Email
amel.jumppanen@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 | 273 | 358 | 68 | 325 |
| Staff expenses | — | — | −29 | −5 | −14 |
| EBITDA | 1 | 232 | 264 | 5 | 261 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 1 | 232 | 264 | 5 | 261 |
| Net financials | −26 | — | −0 | −2 | −3 |
| Profit before tax | −25 | 232 | 238 | 3 | 283 |
| Tax | −0 | −51 | −53 | −2 | −62 |
| Net profit | −25 | 181 | 185 | 1 | 221 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 51 | 339 | 457 | 158 | 417 |
| Equity | 51 | 233 | 238 | 51 | 272 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 0 | 106 | 194 | 82 | 145 |
| Total debt | — | 106 | 194 | 82 | 145 |
EBITDA margin
80.2%
This company
15.8%
Market median
+408% vs market
20202024
Equity ratio
65.1%
This company
38.2%
Market median
+70% vs market
20202024
Return on equity
81.2%
This company
18.4%
Market median
+341% vs market
20202024
Net profit margin
67.9%
This company
8.1%
Market median
+738% vs market
20202024
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20202024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cranium Medicare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Amel Jumppanen | Board of Directors | 0 companies |
| Josef Jumppanen | Deputy Board Member | 0 companies |
| Jamaldin Jaff | Deputy Board Member | 0 companies |